These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2431908)

  • 41. [Importance of cardiocirculatory and pulmonary monitoring in endoscopic retrograde cholangiopancreatography (ERCP)].
    Harloff M; Weber J; Kohler B; Astheimer W; Wagner M; Riemann JF
    Z Gastroenterol; 1991 Aug; 29(8):387-91. PubMed ID: 1950052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of the systemic responses to rapid intravenous injections of ioxilan, iohexol, and diatrizoate in rabbits.
    Morris TW; Prentice L; Ventura J
    Invest Radiol; 1989 Apr; 24(4):294-7. PubMed ID: 2745009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.
    Rudnick MR; Goldfarb S; Wexler L; Ludbrook PA; Murphy MJ; Halpern EF; Hill JA; Winniford M; Cohen MB; VanFossen DB
    Kidney Int; 1995 Jan; 47(1):254-61. PubMed ID: 7731155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization.
    Pelech AN; Allard SM; Hurd RT; Giddins NG; Collins GF
    Invest Radiol; 1991 Jul; 26(7):665-70. PubMed ID: 1885274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangio-pancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS).
    Kruse A; Brock A; Rodenberg J; Nowakowska-Duawa E; Bjartveit K
    Eur Radiol; 1997; 7 Suppl 4():S131-4. PubMed ID: 9204355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A life-threatening contrast-medium reaction during ERCP].
    Zimmerer J; Mainos D; Tittor W; Spannagel B
    Dtsch Med Wochenschr; 1990 Jul; 115(27):1077-8. PubMed ID: 2364886
    [No Abstract]   [Full Text] [Related]  

  • 47. Absorption of contrast medium during ERCP.
    Sable RA; Rosenthal WS; Siegel J; Ho R; Jankowski RH
    Dig Dis Sci; 1983 Sep; 28(9):801-6. PubMed ID: 6884166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative cytotoxicity of low-osmolar nonionic and high-osmolar ionic contrast media to dog gallbladder epithelial cells.
    Ju YM; Kim MH; Lee SK; Seo DW; Min YI; Kim JY
    Gastrointest Endosc; 2002 Mar; 55(3):382-6. PubMed ID: 11868013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of endoscopic sphincterotomy-induced hemorrhage: injection of bleeding site with ERCP contrast solution using a minor papilla diagnostic catheter.
    Lo SK; Patel A
    Gastrointest Endosc; 1993; 39(3):436-9. PubMed ID: 8514083
    [No Abstract]   [Full Text] [Related]  

  • 50. Renal effects and nephrotoxicity of contrast media in renal patients.
    Donadio C; Tramonti G; Giordani R; Lucchetti A; Calderazzi A; Ferrari P; Bianchi C
    Contrib Nephrol; 1993; 101():241-50. PubMed ID: 8467681
    [No Abstract]   [Full Text] [Related]  

  • 51. Side effects of water-soluble contrast agents in upper gastrointestinal tract.
    Gmeinwieser J; Erhardt W; Reimann HJ; Babic R; Speck U; Wenzel-Hora B
    Invest Radiol; 1990 Sep; 25 Suppl 1():S27-8. PubMed ID: 2283247
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal excretion of endoscopic retrograde cholangiopancreatography injected contrast. A common phenomenon.
    Hopper KD; Wegert SJ; Hallgren SE
    Invest Radiol; 1989 May; 24(5):394-6. PubMed ID: 2745022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inadvertent intrathecal use of ionic contrast media for myelography.
    Bøhn HP; Reich L; Suljaga-Petchel K
    AJNR Am J Neuroradiol; 1992; 13(6):1515-9. PubMed ID: 1442425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormonal and biochemical changes following endoscopic retrograde cholangio-pancreatography.
    Tulassay Z; Papp J; Koranyi L; Szathmari M; Tamas G
    Acta Gastroenterol Belg; 1981; 44(11-12):538-44. PubMed ID: 6180583
    [No Abstract]   [Full Text] [Related]  

  • 55. [A case of death following the intravenous administration of an organo-iodinated contrast media of low osmolality].
    Pozzato C; Marozzi F; Brenna F; Gattoni F
    Radiol Med; 1990; 80(1-2):107-8. PubMed ID: 2217926
    [No Abstract]   [Full Text] [Related]  

  • 56. [Tolerance to various radiologic contrast agents used for coronary angiography in patients with acute myocardial infarction].
    Savchenko AP; Frolova MI; Smirnov AA
    Vestn Rentgenol Radiol; 1991; (1):29-32. PubMed ID: 1365505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dacryocystography: comparison of water-soluble and oil-based contrast agents.
    Munk PL; Burhenne LW; Buffam FV; Nugent RA; Lin DT
    Radiology; 1989 Dec; 173(3):827-30. PubMed ID: 2554362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Complications due to the passge of contrast media into the pancreatic tisssue (parenchym staining) during endoscopic retrograde pancreaticography (ERP)].
    Kröger W; Hauzeur F; Rohde L; Sitarek U
    Radiol Diagn (Berl); 1978 Jun; 19(3):326-32. PubMed ID: 693835
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prospects of the use of non-ionic X-ray contrast media during endoscopic retrograde cholangiopancreatography].
    Sviridov NK; Napolov IuK
    Vestn Rentgenol Radiol; 2002; (6):62-3. PubMed ID: 12722628
    [No Abstract]   [Full Text] [Related]  

  • 60. Omnipaque (iohexol).
    Claussen D
    Gastroenterol Nurs; 1992 Jun; 14(6):307-9. PubMed ID: 1623033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.